雷宁和雷宁阻断在补充活动中没有作用
Yuzhou Zhang1, Bertha Martin1, M Ashley Spies2
1Molecular Otolaryngology and Renal Research Laboratories, Carver College of Medicine, University of Iowa, Iowa City, Iowa, USA.
Kidney international
|November 26, 2023
概括
这项研究提供了七条证据,证明氨酸不会分裂补充成分C3. 我们的研究结果驳斥了雷宁激活或失调补体系统的假设.
科学领域:
- 生物化学 生物化学
- 免疫学 免疫学 免疫学
- 脏生理学 脏生理学
背景情况:
- 雷宁是雷宁- ангиотензин系统中的一个关键酶,最近假设它可以切割补充成分C3.
- 补充成分C3通常被C3转化酶,一种血清蛋白酶分裂.
研究的目的:
- 调查并提供关于雷宁在分裂补充成分C3.3中的潜在作用的证据.
- 为了确定雷宁是否有助于补充激活或失调.
主要方法:
- 在患有C3凝聚细胞病变 (C3G) 和非典型血液溶解尿路综合征 (aHUS) 的患者中分析和C3水平.
- 在实验室测试中使用患者血清,复合雷宁和雷宁抑制剂阿利斯基伦.
- 分子建模和对接研究,以评估素-C3相互作用.
主要成果:
- 在C3G和aHUS患者中,血内水平和C3水平之间没有发现相关性.
- 试验室内实验表明,即使使用抑制剂或重组,也没有由素分裂C3.
- 分子建模表明C3不会以催化生产的方式与素的活性部位结合.
结论:
- 这项研究提供了七条证据,驳斥了雷宁分裂C3.3的假设.
- 雷宁似乎没有在补充系统的激活或失调中发挥作用.
相关概念视频
Antihypertensive Drugs: Direct Renin Inhibitors
637
The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
637
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
436
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
436
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
654
Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
654
Antihypertensive Drugs: Angiotensin II Receptor Blockers
748
In the renin-angiotensin-aldosterone system, a hormone called angiotensin II plays a crucial role. It binds to the AT1 receptors in vascular smooth muscles coupled with Gq proteins. The activation of these receptors activates an enzyme called phospholipase C, which releases two molecules: inositol trisphosphate and diacylglycerol. These molecules cause a chain reaction that leads to the phosphorylation of myosin light chains and promotes interaction between actin and myosin, leading to smooth...
748
Antihypertensive Drugs: Action of β1 Blockers
453
β1-receptors are primarily located in the heart and kidneys. In cardiac myocytes, these receptors interact with neurotransmitters released by the sympathetic nervous system during heightened activity or danger. As a result, β1-receptors get activated, initiating a series of biochemical processes. Excessive activation of beta receptors due to chronic stress can abnormally increase heart rate and contractility, resulting in high blood pressure or hypertension. To counteract this,...
453
Hormonal Regulation
33.2K
The renin-aldosterone system is an endocrine system which guides the renal absorption of water and electrolytes, thus managing blood pressure and osmoregulation. Activation of the system begins in the kidneys with a small cluster of cells adjacent to the afferent and efferent blood vessels of the renal corpuscle. As the nephrons are filtering blood, juxtaglomerular cells monitor blood pressure. If they detect a decrease in pressure, they release the hormone renin into the bloodstream.
33.2K


